Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR‐1) Reveals Inverse NOR‐1 Agonists
Daniel Zaienne(Goethe University Frankfurt), Daniel Merk(Goethe University Frankfurt), Jan Heering(Fraunhofer Institute for Translational Medicine and Pharmacology), Silvia Arifi(Goethe University Frankfurt), Julian A. Marschner(Ludwig-Maximilians-Universität München)
Cited by 11
Related Papers
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
The Medicinal Chemistry of Caffeine
|Journal of Medicinal Chemistry|2021|116
<scp>l</scp>-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ
|Journal of Medicinal Chemistry|2020|49
Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation
|Journal of the American Chemical Society|2023|49
Nurr1 Modulation Mediates Neuroprotective Effects of Statins
|Advanced Science|2022|38